NUV 1182
Alternative Names: NUV-1182Latest Information Update: 27 Oct 2020
At a glance
- Originator Nuvation Bio
- Class Antineoplastics
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours